Baloney Inspection Report: Claim #1072 · Inspected Sep 30, 2026, 10:52 AM PDT · Scoring model v2

Radioactive Baloney96%

“contracting an HPV infection is a common side effect of the HPV vaccine”

96%Radioactive Baloney — Dangerously Toxic
Dangerously misleading.
Overwhelmingly falseContradicts known factsPromotes false beliefsPotential for harm
Super Fresh Truth
Fishy Baloney
Stinky Baloney
Rotting Baloney
Radioactive Baloney
Zombie Baloney

✓ BLIND VALIDATION CONFIRMED THIS SCORE

Serve It Fresh

Ready to Serve14 servings

Serve it the way you want it

Download the Rating Card

The Verdict

“contracting an HPV infection is a common side effect of the HPV vaccine”96% Radioactive Baloney — Dangerously ToxicVerified blind by 5 frontier AIs · Baloney Inspection Report: baloney.ai/baloney/contracting-an-hpv-infection-is-a-common-side-effect-of-the

The Rating Card

96% Radioactive Baloney card for this claim

The Baloney Sampler

The HPV vaccine cannot give anyone HPV. As the FDA's approved Gardasil 9 prescribing information, the CDC and the National Cancer Institute all state, the licensed vaccines are recombinant virus-like particles made from a single viral protein (L1). They carry no live virus and no viral genetic material, so nothing can enter cells and replicate — the same reason a hepatitis B surface-antigen vaccine cannot cause hepatitis B.

The safety record points the other way. The CDC's listed common reactions are injection-site pain, redness and swelling, headache, fever, fatigue, nausea, muscle or joint pain and fainting; 'HPV infection' appears on no label or safety summary, and the WHO Global Advisory Committee on Vaccine Safety has repeatedly reaffirmed this. Trials and pooled analyses found HPV and precancer rates lower in vaccinated groups. HPV found after vaccination reflects earlier or non-vaccine types.

Resting on U.S. Food and Drug Administration · U.S. Centers for Disease Control and Prevention · National Cancer Institute (NIH) · WHO Global Advisory Committee on Vaccine Safety

Other ways to slice it — phrasings that might have changed the rating

  1. “People can test positive for HPV after being vaccinated.” The reports accept that post-vaccination HPV detection happens — from infection acquired before vaccination, exposure before protection develops, or a type the vaccine does not cover — without the vaccine causing it.
  2. “The HPV vaccine does not clear an HPV infection someone already has.” CDC guidance cited by the panel states the vaccines prevent new infections but do not treat existing ones, which is why diagnoses can follow vaccination.
  3. “Vials of Gardasil have been reported to contain residual recombinant HPV L1 DNA fragments.” Report 1 notes such fragments were reported in 2011, though the panel found them non-infectious manufacturing remnants with no complete genome, a safety implication the FDA reviewed and rejected.

Written from the panel’s reports by Anthropic · claude-opus-5. Nothing here changed the score.

The Order Ticket

17:52:00CLAIM RECEIVED — QUEUED FOR INSPECTION✓
17:52:00claude-opus-5 REPORT CARRIED OVER FROM THE EARLIER RUN — SCORE 97, CONFIDENCE 97✓
17:52:32gpt-5.5 REPORTED — SCORE 96, CONFIDENCE 96✓
17:52:00gemini-3.1-pro-preview REPORT CARRIED OVER FROM THE EARLIER RUN — SCORE 99, CONFIDENCE 100✓
17:52:00sonar-pro REPORT CARRIED OVER FROM THE EARLIER RUN — SCORE 95, CONFIDENCE 99✓
17:52:00grok-4.6 REPORT CARRIED OVER FROM THE EARLIER RUN — SCORE 90, CONFIDENCE 93✓
17:54:03PRIMARY MASTER CLAUDE — SCORE 97✓
17:52:59BLIND VALIDATION PERPLEXITY — SCORE 98✓
17:53:57AGREEMENT CONFIRMED — DELTA 2✓
17:53:57SCORING MODEL V2 — MEDIAN OF 5 COUNTED LAB SCORES: 97, 96, 99, 95, 90 → 96.✓
17:53:57SOURCE RULE — LABS CITED 25 SOURCES: 0 DISCARDED FOR HAVING NO URL, 0 DISCARDED AS DEAD LINKS (404/410), 6 COULD NOT BE OPENED BY US AND ARE MARKED UNVERIFIED.✓
17:53:57SOURCE RULE — PRIMARY MASTER RULED ON 18 SOURCES: 0 DISCARDED FOR HAVING NO URL, 0 DISCARDED AS DEAD LINKS, 5 MARKED UNVERIFIED, 13 VERIFIED.✓

How This One Was Sliced

Station 1 · Blind Inspection — Five Graders, Zero Peeking

Each lab scored the claim independently, without seeing the others. Open a breakdown for its evidence, its sources, and how sure it was.

Anthropic · EQUAL WEIGHT · 39.4s

claude-opus-5

97%BALONEY

ROUND-1 BREAKDOWN
Evidence offered for the claim
  • No credible evidence supports the claim. The only kernels that get stretched into it: (a) some people vaccinated after sexual debut later test positive for HPV because they were already infected with a vaccine or non-vaccine type before immunization — a timing coincidence, not vaccine-caused infection; (b) genital warts or abnormal Pap results occasionally appear after vaccination, again from pre-existing or non-covered HPV types, since the vaccine is prophylactic and does not clear established infection.
  • Anti-vaccine literature has cited findings of residual recombinant HPV L1 DNA fragments in Gardasil vials (reported by SANE Vax in 2011 and echoed in some later PCR-based claims). This is sometimes offered as 'proof' the vaccine transmits HPV, but the fragments are non-infectious plasmid remnants of the manufacturing process, contain no complete viral genome, and cannot replicate or establish infection — the FDA reviewed and rejected the safety implication.
Evidence against the claim
  • HPV vaccines (Gardasil, Gardasil 9, Cervarix) are non-infectious, recombinant virus-like particle (VLP) vaccines made of the L1 capsid protein only. They contain no viral DNA and therefore cannot replicate or cause HPV infection — this is stated explicitly in the FDA-approved prescribing information and by CDC, WHO and the National Cancer Institute.
  • The actual common side effects listed on the product labels and by CDC are local and systemic reactogenicity: injection-site pain, redness and swelling, headache, fever, nausea, dizziness/fainting (syncope) and fatigue. 'HPV infection' does not appear as an adverse reaction in any package insert or pharmacovigilance summary.
  • Randomized controlled trials and pooled analyses (e.g., the Cochrane review of 26 trials, ~73,000 participants) found HPV rates and precancer rates were substantially LOWER in vaccinated groups, the opposite of what would occur if the vaccine caused infection.
  • Post-licensure surveillance across hundreds of millions of doses (VAERS/VSD in the US, WHO's Global Advisory Committee on Vaccine Safety reviews, and large Nordic and Danish registry cohorts) has identified no signal for vaccine-induced HPV infection. GACVS has repeatedly reaffirmed the vaccines' safety profile.
  • Ecological data confirm the reverse effect: in countries with high coverage, prevalence of vaccine-targeted HPV types fell 80–90% in young women, and cervical cancer incidence in women vaccinated before age 17 has dropped close to zero in Swedish and UK cohort studies.
  • Immunological principle: infection requires an intact viral genome to enter cells and replicate. A capsid-protein shell with no genetic material is biologically incapable of producing an infection, the same reason a hepatitis B surface-antigen vaccine cannot cause hepatitis B.
How sure this lab was

97/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Sources

U.S. Food and Drug Administrationgov · 98 · National Cancer Institute (NIH)gov · 97 · U.S. Centers for Disease Control and Preventiongov · 96 · WHO Global Advisory Committee on Vaccine Safetygov · 95 · Cochrane Database of Systematic Reviews (Arbyn et al., 2018)journal · 94 · New England Journal of Medicine (Lei et al., 2020, HPV vaccination and cervical cancer risk)journal · 95 · UK National Health Servicegov · 92 · Mayo Clinicedu · 90

OpenAI · EQUAL WEIGHT · 32.2s

gpt-5.5

96%BALONEY

ROUND-1 BREAKDOWN
Evidence offered for the claim
  • No good evidence supports the claim as written. The closest kernel is that an HPV diagnosis can occur after vaccination because HPV vaccines prevent new infections best when given before exposure; they do not treat existing HPV infections and do not protect against every HPV type.
  • A temporal association is possible: someone vaccinated after prior exposure, before full immune protection, or later exposed to a non-vaccine HPV type could test positive for HPV. That is not evidence that HPV infection is a vaccine side effect.
Evidence against the claim
  • CDC says HPV vaccines are made from one protein from the virus and are not infectious, meaning they cannot cause HPV infection or cancer.
  • The National Cancer Institute explains that HPV vaccines use virus-like particles that lack viral DNA, so they are noninfectious.
  • The FDA-approved Gardasil 9 label describes the vaccine as recombinant virus-like particles and lists common adverse reactions such as injection-site pain, swelling, redness, and headache—not HPV infection.
  • Large clinical and population studies show HPV vaccination reduces HPV infections and HPV-related disease rather than causing HPV infection.
  • CDC guidance states HPV vaccination prevents new HPV infections but does not treat existing infections, which explains why HPV may be detected after vaccination without being caused by the vaccine.
How sure this lab was

96/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Sources

CDCgov · 95 · National Cancer Institutegov · 95 · FDAgov · 96 · CDCgov · 95 · New England Journal of Medicinejournal · 94 · The Lancetjournal · 93

Google · EQUAL WEIGHT · 21.0s

gemini-3.1-pro-preview

99%BALONEY

ROUND-1 BREAKDOWN
Evidence offered for the claim
  • There is no scientific or medical evidence supporting the claim that the HPV vaccine causes an HPV infection.
  • Misconceptions sometimes arise when individuals who were already unknowingly infected with HPV prior to vaccination are later diagnosed, leading them to falsely attribute the pre-existing infection to the vaccine.
Evidence against the claim
  • HPV vaccines (such as Gardasil 9) are non-infectious. They are manufactured using recombinant technology to create Virus-Like Particles (VLPs).
  • VLPs are empty protein shells that mimic the virus's outer coat to provoke a strong immune response, but they contain absolutely no viral DNA or RNA (neither live nor killed).
  • Because the vaccine lacks any viral genetic material, it cannot reproduce inside the human body. Therefore, it is biologically impossible for the vaccine to cause an HPV infection.
  • Decades of rigorous safety trials and post-market monitoring involving millions of administered doses have never found HPV infection to be a side effect of the vaccine.
  • Major public health and medical organizations, including the CDC, FDA, WHO, and the National Cancer Institute, explicitly confirm that the HPV vaccine cannot cause HPV infections or cancer.
How sure this lab was

100/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Sources

National Cancer Institutegov · 100 · Children's Hospital of Philadelphiaedu · 95 · Mayo Clinicother · 95

Perplexity · EQUAL WEIGHT · 8.6s

sonar-pro

95%BALONEY

ROUND-1 BREAKDOWN
Evidence offered for the claim
  • HPV infection can occur after vaccination if a person was exposed before vaccination, if exposure involves an HPV type not covered by the vaccine, or because the vaccine does not provide complete protection; however, this represents vaccine limitations or coincidental infection, not a vaccine side effect. The available evidence does not support the claim that the vaccine causes HPV infection.
Evidence against the claim
  • The HPV vaccines are noninfectious and do not contain live virus or viral genetic material capable of causing infection. CDC states that the vaccine is made from one viral protein and cannot cause HPV infection or cancer. https://www.cdc.gov/hpv/media/pdfs/2024/07/vaccine-safety.pdf
  • CDC lists common adverse effects as injection-site pain, redness or swelling, fever, headache, fatigue, nausea, and muscle or joint pain; HPV infection is not listed as a common adverse effect. https://www.cdc.gov/vaccine-safety/vaccines/hpv.html
  • WHO reports that the most common adverse events are injection-site reactions and muscle pain, and says HPV vaccines are not live vaccines and cannot cause HPV infection or cancer. https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/topics/human-papillomavirus-vaccines/safety-of-hpv
  • The American Academy of Pediatrics' AAP FactCheck directly describes the claim that HPV vaccines cause HPV infection as false, explaining that the vaccines do not contain live or inactivated viruses. https://www.aap.com.au/factcheck/viral-clip-spreads-misinformation-on-australian-developed-hpv-vaccines/
  • The American College of Obstetricians and Gynecologists states that the HPV vaccine does not contain live viruses and therefore cannot cause HPV infection. https://www.acog.org/womens-health/faqs/hpv-vaccination
How sure this lab was

99/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Sources

U.S. Centers for Disease Control and Preventiongov · 99 · U.S. Centers for Disease Control and Preventiongov · 99 · World Health Organizationgov · 99 · AAP FactCheckfactcheck · 92 · American College of Obstetricians and Gynecologistsother · 94

xAI · EQUAL WEIGHT · 53.5s

grok-4.6

90%BALONEY

ROUND-1 BREAKDOWN
Evidence offered for the claim
  • Anti-vaccination websites and social-media posts sometimes treat a later HPV diagnosis as proof the shot caused infection.
  • Unverified VAERS reports list HPV after vaccination; those reports record temporal association only and do not demonstrate that the vaccine produced the infection.
Evidence against the claim
  • Licensed HPV vaccines (Gardasil, Gardasil 9, Cervarix) contain only recombinant L1 protein assembled into virus-like particles; they have no viral DNA or live virus and therefore cannot infect anyone.
  • CDC, FDA, WHO and the National Cancer Institute state explicitly that the vaccine cannot cause HPV infection.
  • Randomized trials of tens of thousands of participants showed large reductions, not increases, in incident vaccine-type HPV infection and related disease.
  • Post-licensure surveillance covering hundreds of millions of doses has found no signal that the vaccine transmits or causes HPV.
  • HPV is acquired by most sexually active people; diagnoses after vaccination almost always reflect prior infection, non-vaccine HPV types, or ordinary community acquisition, not a vaccine side effect.
  • Documented common side effects are injection-site pain, swelling, headache and syncope, not HPV infection.
How sure this lab was

93/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Sources

National Cancer Institutegov · 97 · World Health Organizationgov · 95 · U.S. Food and Drug Administrationgov · 96

Station 2 · The Masters

Primary Master · drawn at random

claude-opus-5

97% BALONEY

All five evaluators independently reached the same conclusion, with recommended scores clustered tightly between 90 and 99 and confidence between 93 and 100. The claim fails on two separate grounds, and the panel's evidence establishes both. First, biological impossibility: licensed HPV vaccines (Gardasil, Gardasil 9, Cervarix) are recombinant virus-like particles built from the L1 capsid protein alone. They contain no live virus, no inactivated virus, and no viral genome, so there is no genetic material capable of entering cells and replicating — the same reason a hepatitis B surface-antigen vaccine cannot cause hepatitis B. This is stated in the FDA-approved prescribing information and by CDC, WHO, NCI and ACOG. Second, the empirical record: the documented common adverse reactions on the product labels and in CDC/WHO safety summaries are injection-site pain, redness and swelling, headache, fever, fatigue, nausea, muscle or joint pain and syncope. 'HPV infection' appears on no label and in no pharmacovigilance summary. Randomised trials in tens of thousands of participants, and the Cochrane pooled analysis of 26 trials, found vaccine-type HPV infection and precancer rates markedly LOWER in vaccinated arms — the precise opposite of what a vaccine-caused infection would produce — and in high-coverage countries prevalence of vaccine-targeted types has fallen sharply. I weighted the regulatory label and the randomised-trial/registry evidence most heavily, because the claim is a specific pharmacovigilance assertion ('common side effect') that either appears in the safety data or does not, and it does not. The two kernels offered in the claim's defence are both refuted by the panel: post-vaccination HPV diagnoses reflect pre-existing infection, non-vaccine types, or ordinary community acquisition (the vaccine is prophylactic and does not clear established infection), and the residual recombinant L1 DNA fragments reported in vials in 2011 are non-replicating manufacturing remnants with no complete genome, a point the FDA reviewed and rejected. VAERS entries naming HPV record temporal association only and were correctly discounted. I placed the score at 97 rather than 99: the claim is overwhelmingly false and carries real potential for harm by deterring cancer-preventing vaccination, but this particular formulation is one variant within the broader HPV-vaccine misinformation stream rather than a decades-spanning, moon-landing-class fixture with its own sustained debunk history, so the Zombie band is not warranted.

Unanimous on substance: all five evaluators found no credible evidence for the claim and all cited the vaccines' non-infectious virus-like-particle composition as dispositive. All five also independently identified the same source of the misconception — HPV detected after vaccination from pre-existing exposure or non-vaccine types. Disagreement was confined to scoring severity (90 to 99) and to how much attention the fringe arguments deserved: only Report 1 addressed the 2011 residual recombinant L1 DNA-fragment claim and refuted it, and only Report 3 raised unverified VAERS entries, noting they show temporal association only. Report 4 was alone in framing incomplete vaccine coverage explicitly as a limitation rather than a side effect. No evaluator dissented from the conclusion.

Blind Validation Master · never saw the Primary’s work

sonar-pro

98% BALONEY

The statement is overwhelmingly false. All five independent reports agree that HPV vaccines are noninfectious virus-like-particle vaccines made from the L1 capsid protein and lacking viral genetic material, so they cannot replicate or establish an HPV infection. This is consistent with the cited CDC, FDA, and National Cancer Institute evidence. HPV detected after vaccination can reflect infection acquired before vaccination, exposure during the interval before protection develops, or infection with a type not covered by the vaccine; because the vaccines prevent new infections but do not treat existing ones, such timing does not make HPV infection a vaccine side effect. Clinical trials and extensive post-licensure monitoring show prevention or reduction of HPV infection and related disease, while documented common adverse effects are mainly injection-site reactions and short-term systemic symptoms—not HPV infection. A score of 98 reflects that the claim directly contradicts the vaccine’s biological composition and the reported safety and effectiveness evidence, while reserving 99 for a claim that is especially persistent or repeatedly debunked beyond what is established here.

AGREEMENT TEST PASSED — MASTERS SCORED 97% AND 98% · BLIND VALIDATION CONFIRMED THIS SCORE · NO RE-EVALUATION REQUIRED

How the number was reached · scoring model v2 · how our models work

  • Median of 5 counted lab scores: 97, 96, 99, 95, 90 → 96.

The Evidence

Evidence offered for the claim

  • HPV diagnosed after vaccination DEBUNKED — REFUTED. People vaccinated after sexual debut may later test positive for HPV because they were already infected before immunisation. The vaccine is prophylactic and does not clear established infection, so this is a timing coincidence, not vaccine-caused infection.
  • Warts or abnormal Pap results post-vaccination DEBUNKED — REFUTED. These arise from pre-existing infections or from HPV types the vaccine does not cover. HPV is acquired by most sexually active people, so ordinary community acquisition after vaccination is expected and is not a vaccine effect.
  • Residual HPV DNA fragments found in vials DEBUNKED — REFUTED. Recombinant L1 DNA fragments reported in Gardasil vials in 2011 are non-infectious plasmid remnants of the manufacturing process. They contain no complete viral genome and cannot replicate or establish infection; the FDA reviewed and rejected the safety implication.
  • VAERS reports listing HPV after vaccination DEBUNKED — REFUTED. Unverified VAERS entries record only a temporal association between vaccination and a later diagnosis. They do not demonstrate causation, and post-licensure surveillance across hundreds of millions of doses has found no signal of vaccine-caused HPV infection.
  • Incomplete protection against all types DEBUNKED — REFUTED. The vaccine does not cover every HPV type and works best given before exposure. Infection with an uncovered type is a limitation of coverage, not an adverse effect produced by the vaccine.

Evidence against the claim

  • The vaccine contains no viral genome Gardasil, Gardasil 9 and Cervarix are recombinant virus-like particle vaccines made from the L1 capsid protein only — empty protein shells with no live virus, no inactivated virus and no viral DNA or RNA. Infection requires an intact genome to enter cells and replicate, so a capsid shell alone is biologically incapable of producing an infection, for the same reason a hepatitis B surface-antigen vaccine cannot cause hepatitis B.
  • Regulators state it explicitly The FDA-approved prescribing information, CDC, WHO's Global Advisory Committee on Vaccine Safety, the National Cancer Institute and the American College of Obstetricians and Gynecologists all state directly that HPV vaccines are non-infectious and cannot cause HPV infection or cancer.
  • The actual common side effects are different Product labels and CDC and WHO safety summaries list injection-site pain, redness and swelling, headache, fever, fatigue, nausea, muscle or joint pain, and dizziness or fainting. 'HPV infection' does not appear as an adverse reaction in any package insert or pharmacovigilance summary.
  • Trials show the opposite effect Randomised controlled trials in tens of thousands of participants, pooled in a Cochrane review of 26 trials covering roughly 73,000 people, found vaccine-type HPV infection and precancer rates substantially lower in vaccinated groups — the reverse of what would occur if the vaccine caused infection.
  • No safety signal after hundreds of millions of doses Post-licensure surveillance including VAERS and the Vaccine Safety Datalink in the US, WHO GACVS reviews, and large Nordic and Danish registry cohorts has identified no signal for vaccine-induced HPV infection.
  • Population data confirm falling infection rates In countries with high coverage, prevalence of vaccine-targeted HPV types has fallen by 80–90% in young women, and Swedish and UK cohort studies show cervical cancer incidence dropping close to zero among women vaccinated before age 17.
  • Fact-checkers have addressed it directly AAP FactCheck assessed the claim that HPV vaccines cause HPV infection and rated it false, explaining that the vaccines contain neither live nor inactivated viruses.

Sources · Reliability · Why Accepted or Discounted

SourceTypeReliabilityRuling
U.S. Food and Drug Administration (Gardasil 9)gov98ACCEPTED — The licensing regulator's own product page; the approved label is the authoritative statement of composition and of the listed adverse reactions.
National Cancer Institute (NIH)gov97ACCEPTED — Cited independently by four of five evaluators; explains the virus-like-particle mechanism and the absence of viral DNA.
U.S. Centers for Disease Control and Prevention (vaccine safety)gov96ACCEPTED — Primary source for the documented list of common adverse effects, cited by three evaluators.
WHO Global Advisory Committee on Vaccine Safetygov95ACCEPTED — International pharmacovigilance body whose repeated reviews of HPV vaccine safety are directly on point.
Cochrane Database of Systematic Reviews (Arbyn et al., 2018)unverifiedjournal94ACCEPTED — Independent pooled analysis of 26 randomised trials; the strongest available evidence on direction of effect.
New England Journal of Medicine (Lei et al., 2020)unverifiedjournal95ACCEPTED — Peer-reviewed registry cohort on HPV vaccination and cervical cancer risk, supporting the population-level reduction.
UK National Health Servicegov92ACCEPTED — National health service guidance consistent with the regulatory labels; corroborative rather than decisive.
Mayo Clinicunverifiededu90ACCEPTED — Reputable clinical patient information cited by two evaluators; supporting, not load-bearing.
Children's Hospital of Philadelphia Vaccine Education Centeredu95ACCEPTED — Specialist academic vaccine education centre; accurate on the virus-like-particle mechanism.
World Health Organization (HPV and cervical cancer fact sheet)gov95ACCEPTED — Standard international reference on HPV epidemiology and vaccine effect.
U.S. Centers for Disease Control and Prevention (HPV vaccine safety PDF)gov99ACCEPTED — Direct CDC statement that the vaccine is made from one viral protein and cannot cause HPV infection or cancer.
WHO GACVS — Safety of HPV vaccinesgov99ACCEPTED — The specific WHO safety page addressing both common adverse events and the non-live nature of the vaccines.
AAP FactCheckfactcheck92ACCEPTED — An established news-agency fact-check addressing this exact claim and rating it false. Accepted on its own terms; note that the evaluator's attribution of this URL to the American Academy of Pediatrics appears mistaken, and it is treated here as a fact-check source rather than a medical body.
American College of Obstetricians and Gynecologistsother94ACCEPTED — Relevant professional medical society stating the vaccine contains no live virus and cannot cause HPV infection.
U.S. Food and Drug Administration (Gardasil 9 label download)gov96ACCEPTED — The approved prescribing information itself — the definitive list of common adverse reactions, which does not include HPV infection.
U.S. Centers for Disease Control and Prevention (HPV recommendations)gov95ACCEPTED — Establishes that vaccination prevents new infections but does not treat existing ones, explaining post-vaccination detections.
New England Journal of Medicine (FUTURE II trial)unverifiedjournal94ACCEPTED — Peer-reviewed randomised trial evidence of reduced HPV-related disease after vaccination.
The Lancet (vaccine impact meta-analysis)unverifiedjournal93ACCEPTED — Peer-reviewed population-level analysis documenting declines in HPV prevalence after vaccination programmes.

Every link was opened when this claim was inspected. A dead link was discarded before publication; “unverified” means the site refused our automated check and the link is the one the panel cited. A source without a URL was never kept.

Serve It Fresh

Ready to Serve14 servings

Serve it the way you want it

Download the Rating Card

The Verdict

“contracting an HPV infection is a common side effect of the HPV vaccine”96% Radioactive Baloney — Dangerously ToxicVerified blind by 5 frontier AIs · Baloney Inspection Report: baloney.ai/baloney/contracting-an-hpv-infection-is-a-common-side-effect-of-the